CN1188426C - 抗磷酸化vasp(血管舒张剂刺激磷蛋白)的抗体,用于它们的制备的杂交瘤细胞和它们的用途 - Google Patents
抗磷酸化vasp(血管舒张剂刺激磷蛋白)的抗体,用于它们的制备的杂交瘤细胞和它们的用途 Download PDFInfo
- Publication number
- CN1188426C CN1188426C CNB988114542A CN98811454A CN1188426C CN 1188426 C CN1188426 C CN 1188426C CN B988114542 A CNB988114542 A CN B988114542A CN 98811454 A CN98811454 A CN 98811454A CN 1188426 C CN1188426 C CN 1188426C
- Authority
- CN
- China
- Prior art keywords
- vasp
- phosphorylation
- antibody
- serine
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Bioinformatics & Computational Biology (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
Abstract
Description
Claims (12)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19749091A DE19749091C1 (de) | 1997-11-07 | 1997-11-07 | Antikörper gegen phosphoryliertes VASP (Vasodilator-Stimuliertes Phosphoprotein), Hybridomzellen zu dessen Herstellung sowie dessen Anwendung |
DE19749091.3 | 1997-11-07 | ||
US7937598P | 1998-03-26 | 1998-03-26 | |
US60/079,375 | 1998-03-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1279691A CN1279691A (zh) | 2001-01-10 |
CN1188426C true CN1188426C (zh) | 2005-02-09 |
Family
ID=26041380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB988114542A Expired - Fee Related CN1188426C (zh) | 1997-11-07 | 1998-11-06 | 抗磷酸化vasp(血管舒张剂刺激磷蛋白)的抗体,用于它们的制备的杂交瘤细胞和它们的用途 |
Country Status (16)
Country | Link |
---|---|
US (2) | US6649421B1 (zh) |
EP (1) | EP1042368B1 (zh) |
JP (1) | JP5031140B2 (zh) |
KR (1) | KR100513418B1 (zh) |
CN (1) | CN1188426C (zh) |
AT (1) | ATE248189T1 (zh) |
AU (1) | AU753557B2 (zh) |
BR (1) | BR9813988A (zh) |
CA (1) | CA2308604C (zh) |
CZ (1) | CZ299889B6 (zh) |
ES (1) | ES2205593T3 (zh) |
HU (1) | HU222411B1 (zh) |
PL (1) | PL195985B1 (zh) |
RU (1) | RU2218178C2 (zh) |
TR (1) | TR200001265T2 (zh) |
WO (1) | WO1999024473A1 (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10029210A1 (de) * | 2000-06-14 | 2002-01-31 | Vasopharm Biotech Gmbh & Co Kg | Testsystem sowie dessen Verwendung |
US6951947B2 (en) * | 2000-07-13 | 2005-10-04 | The Scripps Research Institute | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
US7176037B2 (en) * | 2000-07-13 | 2007-02-13 | The Scripps Research Institute | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
EP1182263A1 (en) * | 2000-08-11 | 2002-02-27 | Evotec OAI AG | Process for detecting threonine/serine kinase activity |
US20030162230A1 (en) | 2000-09-27 | 2003-08-28 | Reagan Kevin J. | Method for quantifying phosphokinase activity on proteins |
WO2002050121A1 (fr) * | 2000-12-13 | 2002-06-27 | Taisho Pharmaceutical Co.,Ltd. | Nouvel anticorps |
JP2007529718A (ja) * | 2004-03-12 | 2007-10-25 | ザ スクリップス リサーチ インスティチュート | 蛋白質活性の検出および定量のための蛍光シグナル発光型生細胞バイオセンサー分子ならびに色素 |
CN103102411A (zh) * | 2009-06-11 | 2013-05-15 | 北京华大蛋白质研发中心有限公司 | 一种制备针对糖基化修饰蛋白质的单克隆抗体杂交瘤的方法 |
FR2946756A1 (fr) * | 2009-06-12 | 2010-12-17 | Biocytex | Dosage en sang total d'un biomarqueur intracellulaire appartenant a une voie de signalisation cellulaire- utilisation pour mesurer l'activation d'une population cellulaire determinee |
EP3509613A4 (en) * | 2016-09-07 | 2020-12-02 | Vanderbilt University | VASOACTIVE POLYPEPTIDE FOR THE RELAXATION OF SMOOTH MUSCLES |
CN112730826A (zh) * | 2020-12-23 | 2021-04-30 | 中南大学湘雅三医院 | 一种人磷酸化血管扩张刺激磷蛋白磁微粒化学发光免疫定量检测试剂盒及其检测方法和应用 |
CN113238062B (zh) * | 2021-07-13 | 2021-09-28 | 湖南菲思特精准医疗科技有限公司 | 一种用于人磷酸化血管扩张刺激磷蛋白光激化学发光均相免疫检测试剂盒及其检测方法 |
CN114002440B (zh) * | 2021-12-30 | 2022-04-01 | 湖南菲思特精准医疗科技有限公司 | 一种用于人磷酸化血管扩张刺激蛋白的酶联免疫检测试剂盒及其检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2117913C (en) | 1992-04-10 | 2006-05-09 | Richard J. Epstein | Activation-state-specific phosphoprotein immunodetection |
-
1998
- 1998-11-06 AT AT98963419T patent/ATE248189T1/de not_active IP Right Cessation
- 1998-11-06 PL PL98340465A patent/PL195985B1/pl not_active IP Right Cessation
- 1998-11-06 BR BR9813988-6A patent/BR9813988A/pt not_active IP Right Cessation
- 1998-11-06 US US09/530,864 patent/US6649421B1/en not_active Expired - Fee Related
- 1998-11-06 CZ CZ20001684A patent/CZ299889B6/cs not_active IP Right Cessation
- 1998-11-06 HU HU0004099A patent/HU222411B1/hu not_active IP Right Cessation
- 1998-11-06 WO PCT/EP1998/007103 patent/WO1999024473A1/en active IP Right Grant
- 1998-11-06 AU AU18712/99A patent/AU753557B2/en not_active Ceased
- 1998-11-06 CN CNB988114542A patent/CN1188426C/zh not_active Expired - Fee Related
- 1998-11-06 TR TR2000/01265T patent/TR200001265T2/xx unknown
- 1998-11-06 ES ES98963419T patent/ES2205593T3/es not_active Expired - Lifetime
- 1998-11-06 KR KR10-2000-7004901A patent/KR100513418B1/ko not_active IP Right Cessation
- 1998-11-06 RU RU2000114841/14A patent/RU2218178C2/ru not_active IP Right Cessation
- 1998-11-06 CA CA002308604A patent/CA2308604C/en not_active Expired - Fee Related
- 1998-11-06 EP EP98963419A patent/EP1042368B1/en not_active Expired - Lifetime
- 1998-11-06 JP JP2000520481A patent/JP5031140B2/ja not_active Expired - Fee Related
-
2003
- 2003-09-22 US US10/664,970 patent/US20040063914A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CZ20001684A3 (cs) | 2000-11-15 |
HUP0004099A3 (en) | 2002-01-28 |
PL340465A1 (en) | 2001-02-12 |
EP1042368B1 (en) | 2003-08-27 |
ATE248189T1 (de) | 2003-09-15 |
ES2205593T3 (es) | 2004-05-01 |
HUP0004099A1 (en) | 2001-03-28 |
CA2308604A1 (en) | 1999-05-20 |
RU2218178C2 (ru) | 2003-12-10 |
CN1279691A (zh) | 2001-01-10 |
KR20010031830A (ko) | 2001-04-16 |
BR9813988A (pt) | 2000-09-26 |
US20040063914A1 (en) | 2004-04-01 |
TR200001265T2 (tr) | 2000-09-21 |
JP5031140B2 (ja) | 2012-09-19 |
CZ299889B6 (cs) | 2008-12-29 |
CA2308604C (en) | 2009-12-15 |
WO1999024473A1 (en) | 1999-05-20 |
EP1042368A1 (en) | 2000-10-11 |
AU753557B2 (en) | 2002-10-24 |
PL195985B1 (pl) | 2007-11-30 |
HU222411B1 (hu) | 2003-06-28 |
JP2001522865A (ja) | 2001-11-20 |
KR100513418B1 (ko) | 2005-09-09 |
US6649421B1 (en) | 2003-11-18 |
AU1871299A (en) | 1999-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1188426C (zh) | 抗磷酸化vasp(血管舒张剂刺激磷蛋白)的抗体,用于它们的制备的杂交瘤细胞和它们的用途 | |
US7459156B2 (en) | Antibodies that mimic actions of neurotrophins | |
JP4199223B2 (ja) | ヒトtrk受容体および神経栄養因子インヒビター | |
DK175949B1 (da) | Fremgangsmåde til fremstilling af en ligand-bindende, dimeriseret polypeptidfusion, samt dimeriseret polypeptidfusion fremstillet ved denne fremgangsmåde | |
TWI485160B (zh) | 抗cd6單株抗體於治療疾病之用途 | |
US5750375A (en) | Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions | |
Plun‐Favreau et al. | The ciliary neurotrophic factor receptor α component induces the secretion of and is required for functional responses to cardiotrophin‐like cytokine | |
US20180162919A1 (en) | Multivalent regulatory t cell modulators | |
JP2009035563A (ja) | ヒトtrk受容体および神経栄養因子インヒビター | |
McGillis et al. | Circadian rhythm of thymosin-alpha 1 in normal and thymectomized mice. | |
JP2020527727A (ja) | 診断方法 | |
JP2022520868A (ja) | 抗trem2抗体及びその使用方法 | |
EP0792294A1 (en) | Human antibodies to t-cell receptor peptides and methods for their preparation | |
FR2599513A1 (fr) | Anticorps monoclonaux inhibant la liaison de ige soluble aux lymphocytes humains, hybridomes monoclonaux produisant de tels anticorps, leur utilisation | |
WO1990011520A1 (fr) | Anticorps contre une chaine lourde de myosine des muscles lisses | |
JPH0795945B2 (ja) | 白血球の活性化を監視するためのモノクローナル抗体 | |
US20220332809A1 (en) | Monoclonal antibodies against bambi and use thereof for treating inflammatory diseases | |
EP1388543A2 (en) | Antibodies against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use | |
Janiak et al. | Tubulin is not phosphorylated in resting and thrombin-activated platelets | |
Marchalonis | Antigen recognition by T lymphocytes: Status of the minimal hypothesis | |
JP2023552226A (ja) | Cd47に特異的な抗体及びその使用 | |
MXPA00004331A (en) | Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use | |
Slanetz | The production and characterization of soluble T cell receptor molecules | |
EP0305619A1 (en) | Monoclonal antibody, process for preparation thereof and diagnostic drug containing the same | |
FR2969761A1 (fr) | Procede de dosage d'anticorps diriges contre le facteur viii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BIOLOGICAL THAITEKS CO., LTD. Free format text: FORMER OWNER: VASOPHARM BIOTECH GMBH Effective date: 20100406 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: GERMANY WURZBURG TO: MARSEILLES,FRANCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100406 Address after: France Marseille Patentee after: Bio tech company Address before: Germany Wuerzburg Patentee before: Vasopharm Biotech GmbH |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050209 Termination date: 20151106 |
|
EXPY | Termination of patent right or utility model |